Praxis Precision Medicines

Praxis Precision Medicines is a clinical-stage biopharmaceutical company that develops therapies for central nervous system (CNS) disorders. It focuses on diseases caused by neuronal excitation-inhibition imbalance, including epilepsy and movement disorders. Its pipeline includes ulixacaltamide (essential tremor), vormatrigine (epilepsy), and relutrigine (developmental and epileptic encephalopathies).